News

The AM Reporter13h
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 3,405 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in AnaptysBio, Inc. (NASDAQ:ANAB – ...
Switching off key gene makes NK cells more sensitive to cancer-fighting signals
All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...
Equity Insider: As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...
Mirage News7h
Empowering NK Cells in Cancer Fight
All of us produce a growth factor – called IL-15 – which effectively protects us from cancers. It's role is to boost the ...
Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight
The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK ...
The American Journal of Managed Care40m
Subcutaneous Tocilizumab Superior to Methotrexate in Chinese Patients With RA
Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately ...
Aplastic Anemia Treatment Market Size In The 7MM Was ~USD 270 Million In 2023 And Is Further Expected To Increase By 2034, Estimates Delveinsight
Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
"Lymphopenia has long been recognized as a major driver and predictor of early mortality in cancer—yet until now, it has ...